Siemens to list Healthineers in Frankfurt next year

FRANKFURT/MUNICH (Reuters) - The supervisory board of Siemens AG SIEGn.DE agreed on Wednesday to prepare to list its Healthineers medical equipment business on the Frankfurt stock exchange in the first half of 2018.

FILE PHOTO - Siemens AG logo is seen at new headquarters in Munich, Germany, June 14, 2016. REUTERS/Michaela Rehle

The move comes as the German industrial conglomerate is seeking to simplify its structure and the Healthineers spin-off will be the country's biggest share offering since Deutsche Telekom DTEGn.DE listed in 1996, potentially valuing the company at 40 billion euros ($47.5 billion).

“The public listing is the next logical step and the foundation for expanding our strong position as a leading global supplier of healthcare technology,” Michael Sen, chairman of the Siemens Healthineers supervisory board, said in a statement.

“Frankfurt is one of the world’s largest trading centers for securities, and its importance will continue to increase due to Brexit. As a highly liquid trading venue, Frankfurt is attractive for investors from around the world,” he added.

Sen had previously highlighted the attractions of a listing in New York, where most of Healthineers’ peers are listed, pointing also to high liquidity and expertise about the sector among the financial community.

But Frankfurt is seeking to gain in stature as banks prepare to move staff there from London ahead of Britain’s divorce from the European Union.

With the initial public share offer Siemens is expected to sell 15-25 percent of Healthineers, which makes X-ray and MRI machines, sources familiar with the matter have said. That implies stock worth 6-10 billion euros could be put up for sale.

Siemens has already appointed Goldman Sachs GS.N, Deutsche Bank DBKGn.DE and JP Morgan JPM.N as lead organizers for the Healthineers share sale.

It said BNP Paribas, BofA Merrill Lynch, Citigroup and UBS were engaged as further syndicate banks

($1 = 0.8425 euros)

Reporting by Arno Schuetze and Alexander Huebner; Writing by Douglas Busvine, Georgina Prodhan and Emma ThomassonEditing by Keith Weir, Greg Mahlich